Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Csf3rtm1Link mutation
(1 available);
any
Csf3r mutation
(42 available)
|
|
|
immune system
|
• no mobilization in response to granulocyte-colony stimulating factor (G-CSF)
|
cellular
|
• no mobilization in response to granulocyte-colony stimulating factor (G-CSF)
|
hematopoietic system
|
• no mobilization in response to granulocyte-colony stimulating factor (G-CSF)
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Csf3rtm1Link mutation
(1 available);
any
Csf3r mutation
(42 available)
|
|
|
immune system
|
• chemotaxis response to Il8 is significantly reduced
|
cellular
|
• chemotaxis response to Il8 is significantly reduced
|
hematopoietic system
|
• chemotaxis response to Il8 is significantly reduced
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Csf3rtm1Link mutation
(1 available);
any
Csf3r mutation
(42 available)
|
|
|
hematopoietic system
|
• decreased numbers of mature myeloid cells in bone marrow but normal megakaryocyte levels and overall cellularity is normal
|
|
• metamyelocytes and granulocyte numbers are reduced 50%
|
|
• 12% normal levels of circulating neutrophils while other blood cell counts are normal
|
|
• total numbers of hematopoietic progenitor cells in bone marrow is reduced
|
|
• higher levels of apoptosis in cultured bone marrow mononuclear cells
|
|
• monocyte numbers in peripheral blood are reduced about 50%
|
immune system
|
• 12% normal levels of circulating neutrophils while other blood cell counts are normal
|
|
• higher levels of apoptosis in cultured bone marrow mononuclear cells
|
|
• monocyte numbers in peripheral blood are reduced about 50%
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Adam10tm1.1Khr mutation
(0 available);
any
Adam10 mutation
(37 available)
Csf3rtm1Link mutation
(1 available);
any
Csf3r mutation
(42 available)
Tg(Mx1-cre)1Cgn mutation
(7 available)
|
|
|
hematopoietic system
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• pIpC-treated mice exhibit an increase in Gr1+CD11b+ myeloid cells in the spleen compared with Csf3rtm1Link homozygotes
|
cellular
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
immune system
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• pIpC-treated mice exhibit an increase in Gr1+CD11b+ myeloid cells in the spleen compared with Csf3rtm1Link homozygotes
|
growth/size/body
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|
|
• in pIpC-treated mice to a lesser extent than in mice with wild-type Csf3r
|